Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rare bleeding disorders.
Peyvandi F, Cattaneo M, Inbal A, De Moerloose P, Spreafico M. Peyvandi F, et al. Among authors: de moerloose p. Haemophilia. 2008 Jul;14 Suppl 3:202-10. doi: 10.1111/j.1365-2516.2008.01751.x. Haemophilia. 2008. PMID: 18510543 Review.
The role of prophylaxis in bleeding disorders.
Berntorp E, de Moerloose P, Ljung RC. Berntorp E, et al. Among authors: de moerloose p. Haemophilia. 2010 Jul;16 Suppl 5:189-93. doi: 10.1111/j.1365-2516.2010.02319.x. Haemophilia. 2010. PMID: 20590880 Review.
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations.
Hermans C, De Moerloose P, Fischer K, Holstein K, Klamroth R, Lambert T, Lavigne-Lissalde G, Perez R, Richards M, Dolan G; European Haemophilia Therapy Standardisation Board. Hermans C, et al. Among authors: de moerloose p. Haemophilia. 2011 May;17(3):383-92. doi: 10.1111/j.1365-2516.2010.02449.x. Epub 2011 Feb 15. Haemophilia. 2011. PMID: 21323794 Review.
Rare bleeding disorders.
Peyvandi F, Bolton-Maggs PH, Batorova A, De Moerloose P. Peyvandi F, et al. Among authors: de moerloose p. Haemophilia. 2012 Jul;18 Suppl 4:148-53. doi: 10.1111/j.1365-2516.2012.02841.x. Haemophilia. 2012. PMID: 22726099 Review.
Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia.
Casini A, von Mackensen S, Santoro C, Djambas Khayat C, Belhani M, Ross C, Dorgalaleh A, Naz A, Ünal E, Abdelwahab M, Lozeron ED, Trillot N, Susen S, Peyvandi F, de Moerloose P; QualyAfib Study Group. Casini A, et al. Among authors: de moerloose p. Blood. 2021 Jun 3;137(22):3127-3136. doi: 10.1182/blood.2020009472. Blood. 2021. PMID: 33512441 Free article. Clinical Trial.
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.
Mohsenian S, Palla R, Menegatti M, Cairo A, Lecchi A, Casini A, Neerman-Arbez M, Asselta R, Scardo S, Siboni SM, Blatny J, Zapletal O, Schved JF, Giansily-Blaizot M, Halimeh S, Daoud MA, Platokouki H, Pergantou H, Schutgens REG, Van Haaften-Spoor M, Brons P, Laros-van Gorkom B, Van Pinxten E, Borhany M, Fatima N, Mikovic D, Saracevic M, Özdemir GN, Ay Y, Makris M, Lockley C, Mumford A, Harvey A, Austin S, Shapiro A, Williamson A, McGuinn C, Goldberg I, De Moerloose P, Peyvandi F. Mohsenian S, et al. Among authors: de moerloose p. Blood Adv. 2024 Mar 26;8(6):1392-1404. doi: 10.1182/bloodadvances.2023012186. Blood Adv. 2024. PMID: 38286442 Free PMC article.
440 results